Format

Send to

Choose Destination
See comment in PubMed Commons below
Radiat Oncol J. 2013 Dec;31(4):216-21. doi: 10.3857/roj.2013.31.4.216. Epub 2013 Dec 31.

Short-course palliative radiotherapy for uterine cervical cancer.

Author information

1
Department of Radiation Oncology, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
2
Department of Radiation Oncology, Pusan National University Yangsan Hospital, Yangsan, Korea.
3
Department of Radiation Oncology, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea. ; Department of Radiation Oncology, Pusan National University School of Medicine, Busan, Korea.

Abstract

PURPOSE:

The purpose of this retrospective study was to evaluate the efficacy and feasibility of short-course hypofractionated radiotherapy (RT) for the palliation of uterine cervical cancer.

MATERIALS AND METHODS:

Seventeen patients with cancer of the uterine cervix, who underwent palliative hypofractionated 3-dimensional conformal radiotherapy between January 2002 and June 2012, were retrospectively analyzed. RT was delivered to symptomatic lesions (both the primary mass and/or metastatic regional lymph nodes). The total dose was 20 to 25 Gy (median, 25 Gy) in 5 Gy daily fractions.

RESULTS:

The median follow-up duration was 12.2 months (range, 4 to 24 months). The median survival time was 7.8 months (range, 4 to 24 months). Vaginal bleeding was the most common presenting symptom followed by pelvic pain (9 patients). The overall response rates were 93.8% and 66.7% for vaginal bleeding control and pelvic pain, respectively. Nine patients did not have any acute side effects and 7 patients showed minor gastrointestinal toxicity. Only 1 patient had grade 3 diarrhea 1 week after completion of treatment, which was successfully treated conservatively. Late complications occurred in 4 patients; however, none of these were of grade 3 or higher severity.

CONCLUSION:

Short-course hypofractionated RT was effective and well tolerated as palliative treatment for uterine cervical cancer.

KEYWORDS:

Carcinoma; Cervix uteri; Hypofractionation; Palliation; Radiotherapy

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Publishing M2Community Icon for PubMed Central
    Loading ...
    Support Center